WeMicrobio (688351.SH) announced its semi-annual report for the year 2024, with operating revenue of 0.198 billion yuan, a year-on-year growth of 39.57%; net income attributable to shareholders of listed companies was 17.0127 million yuan, a year-on-year growth of 689.30%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 0.9217 million yuan, turning losses into profits year-on-year; basic earnings per share were 0.0362 yuan.
The increase in revenue by 39.57% compared to the same period last year is mainly due to the continuous expansion of the company's business scale and the increase in product sales volume during the reporting period.